EP Patent

EP2398463A1 — A method for amphiphilic drug loading in liposomes by ion gradient

Assigned to Instytut Farmaceutiyczny · Expires 2011-12-28 · 14y expired

What this patent protects

An active loading of amphophilic drugs, especially anthracycline antibiotics, in liposomes using conventional lipid compositions, is achieved by applying salts of polycarboxylic acids with mono- or divalent cations, preferably selected from sodium, potassium, calcium, magnesium o…

USPTO Abstract

An active loading of amphophilic drugs, especially anthracycline antibiotics, in liposomes using conventional lipid compositions, is achieved by applying salts of polycarboxylic acids with mono- or divalent cations, preferably selected from sodium, potassium, calcium, magnesium or ammonium salt of ethylenediaminotetraacetic acid (EDTA) or ethyleneglycol-O-O'-bis(2-aminoethyl)-N,N,N',N'-tetraacetic acid (EGTA). The liposomal formulations obtained by the method of active loading of drugs to liposomes by EDTA or EGTA salts gradient are characterized by high loading efficiency, feature microcrystalline deposits of anthracyclines inside liposomes, which renders them stable and not susceptible to leakage. The liposomes are unilamellar and their size is close to 100 nanometers after drug loading.

Drugs covered by this patent

Patent Metadata

Patent number
EP2398463A1
Jurisdiction
EP
Classification
Expires
2011-12-28
Drug substance claim
No
Drug product claim
No
Assignee
Instytut Farmaceutiyczny
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.